Qlaira 3 mg + 2 mg - 2 mg + 3 mg - 2 mg + 1 mg (estradiol valeraat 3 mg tablet (or.) (I) + estradiol valeraat 2 mg + diënogest 2 mg tablet (or.) (II) + estradiol valeraat 2 mg + diënogest 3 mg tablet (or.) (III) + estradiol valeraat 1 mg tablet (or.) (IV) + placebo tablet (or.) (V)) · CNK 2597003

Product information

Qlaira 3 mg + 2 mg - 2 mg + 3 mg - 2 mg + 1 mg
3 x 28 (2 + 5 + 17 + 2 + 2)
estradiol valeraat 3 mg tablet (or.) (I) + estradiol valeraat 2 mg + diënogest 2 mg tablet (or.) (II) + estradiol valeraat 2 mg + diënogest 3 mg tablet (or.) (III) + estradiol valeraat 1 mg tablet (or.) (IV) + placebo tablet (or.) (V)
2597003
9.95 / 10
Locked

Product properties

979-32-8
G03AB08
Bayer
Film-coated tablet
BE327792
04057598002165
M2
Public
327792-02

Pharmacist Assessment

Normally available

This product has good current availability (score 9.95/10) and is historically stable (score 🔒/10). No action required.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 18 of 18 warehouse locations have stock
  • 3 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Available Active
Published 29/10/2025

Composition

12 ingredients

Substance Type Strength CAS
Active ingredient
3 mg
979-32-8
Excipient
48.36 mg
Active ingredient
2 mg
65928-58-7
Active ingredient
2 mg
979-32-8
Excipient
47.36 mg
Active ingredient
3 mg
65928-58-7
Active ingredient
2 mg
979-32-8
Excipient
46.36 mg
Active ingredient
1 mg
979-32-8
Excipient
50.36 mg
Active ingredient
Excipient
52.1455 mg

Additional information

Availability statistics

Available
0 days
2
0